|
CRIM1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.020530E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.447640E-02 |
| Normal-vs-Stage2 |
1.260400E-01 |
| Normal-vs-Stage3 |
6.374500E-04 |
| Normal-vs-Stage4 |
2.24209999999392E-06 |
| Stage1-vs-Stage2 |
9.845400E-01 |
| Stage1-vs-Stage3 |
8.487800E-02 |
| Stage1-vs-Stage4 |
1.223200E-03 |
| Stage2-vs-Stage3 |
3.112000E-01 |
| Stage2-vs-Stage4 |
3.182400E-02 |
| Stage3-vs-Stage4 |
9.422400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.624400E-03 |
| Normal-vs-AfricanAmerican |
4.650300E-02 |
| Normal-vs-Asian |
9.231900E-02 |
| Caucasian-vs-AfricanAmerican |
8.049800E-01 |
| Caucasian-vs-Asian |
9.186000E-01 |
| AfricanAmerican-vs-Asian |
8.025600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.261040E-03 |
| Normal-vs-Female |
2.415700E-03 |
| Male-vs-Female |
4.674600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.186200E-02 |
| Normal-vs-Age(41-60Yrs) |
3.639300E-03 |
| Normal-vs-Age(61-80Yrs) |
1.354660E-04 |
| Normal-vs-Age(81-100Yrs) |
6.890300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.244620E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.880700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.338800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.736790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.959000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.138000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.597700E-03 |
| Classical-VS-Follicular |
1.992770E-04 |
| Classical-VS-Other |
2.698600E-01 |
| Classical-VS-Normal |
6.250000E-02 |
| Tall-VS-Follicular |
5.696000E-01 |
| Tall-VS-Other |
8.846000E-01 |
| Tall-VS-Normal |
3.035700E-04 |
| Follicular-VS-Other |
9.002000E-01 |
| Follicular-VS-Normal |
1.57897999999435E-05 |
| Other-VS-Normal |
3.954200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.154720E-04 |
| Normal-vs-N1 |
1.191590E-02 |
| N0-vs-N1 |
8.244200E-01 |
|
|
